

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * protoporphyrinogen IX metabolic process (GO:0046501) | 8.33963701 |
| 2 | * protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.31616404 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.21487597 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.21487597 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.77851241 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.77851241 |
| 7 | nuclear pore complex assembly (GO:0051292) | 6.25350440 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.10947140 |
| 9 | mitotic chromosome condensation (GO:0007076) | 5.76143870 |
| 10 | cysteine metabolic process (GO:0006534) | 5.75506738 |
| 11 | DNA unwinding involved in DNA replication (GO:0006268) | 5.75359639 |
| 12 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 5.74352563 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.38778835 |
| 14 | nuclear pore organization (GO:0006999) | 5.31184382 |
| 15 | * heme biosynthetic process (GO:0006783) | 5.28378641 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.26204394 |
| 17 | * porphyrin-containing compound metabolic process (GO:0006778) | 5.24253244 |
| 18 | * tetrapyrrole biosynthetic process (GO:0033014) | 5.19841107 |
| 19 | heme transport (GO:0015886) | 5.15213671 |
| 20 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.14720131 |
| 21 | bile acid biosynthetic process (GO:0006699) | 5.14197777 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 5.11471541 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 5.11471541 |
| 24 | tryptophan catabolic process (GO:0006569) | 5.11471541 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.00704077 |
| 26 | kynurenine metabolic process (GO:0070189) | 5.00565435 |
| 27 | * heme metabolic process (GO:0042168) | 4.89642215 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.83429115 |
| 29 | lysine metabolic process (GO:0006553) | 4.79271272 |
| 30 | lysine catabolic process (GO:0006554) | 4.79271272 |
| 31 | tryptophan metabolic process (GO:0006568) | 4.79227880 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 4.72023089 |
| 33 | regulation of translational fidelity (GO:0006450) | 4.63906929 |
| 34 | plasma lipoprotein particle assembly (GO:0034377) | 4.63176004 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.61003930 |
| 36 | protein carboxylation (GO:0018214) | 4.60009944 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.60009944 |
| 38 | mitotic sister chromatid segregation (GO:0000070) | 4.53636224 |
| 39 | pore complex assembly (GO:0046931) | 4.46889751 |
| 40 | formation of translation preinitiation complex (GO:0001731) | 4.45907549 |
| 41 | urea cycle (GO:0000050) | 4.43291892 |
| 42 | urea metabolic process (GO:0019627) | 4.43291892 |
| 43 | bile acid metabolic process (GO:0008206) | 4.42507569 |
| 44 | regulation of protein activation cascade (GO:2000257) | 4.38818274 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 4.38200975 |
| 46 | fatty acid elongation (GO:0030497) | 4.36932836 |
| 47 | protein-lipid complex assembly (GO:0065005) | 4.35087354 |
| 48 | DNA topological change (GO:0006265) | 4.31846221 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.31571262 |
| 50 | sister chromatid segregation (GO:0000819) | 4.30709712 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.30651632 |
| 52 | serine family amino acid metabolic process (GO:0009069) | 4.28312289 |
| 53 | serine family amino acid biosynthetic process (GO:0009070) | 4.27039950 |
| 54 | regulation of sister chromatid cohesion (GO:0007063) | 4.26064544 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 4.24266077 |
| 56 | glutamate metabolic process (GO:0006536) | 4.23487102 |
| 57 | hemoglobin metabolic process (GO:0020027) | 4.21317460 |
| 58 | cofactor catabolic process (GO:0051187) | 4.21107050 |
| 59 | nitrogen cycle metabolic process (GO:0071941) | 4.20241261 |
| 60 | complement activation, alternative pathway (GO:0006957) | 4.19626163 |
| 61 | glycine metabolic process (GO:0006544) | 4.15511814 |
| 62 | cholesterol efflux (GO:0033344) | 4.14935202 |
| 63 | proline biosynthetic process (GO:0006561) | 4.13738573 |
| 64 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.13661947 |
| 65 | * response to methylmercury (GO:0051597) | 4.12940889 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 4.12266410 |
| 67 | regulation of RNA export from nucleus (GO:0046831) | 4.11817167 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 4.10573982 |
| 69 | amino-acid betaine metabolic process (GO:0006577) | 4.09424417 |
| 70 | mitotic sister chromatid cohesion (GO:0007064) | 4.08196882 |
| 71 | reverse cholesterol transport (GO:0043691) | 4.08106181 |
| 72 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.06338198 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 4.05895658 |
| 74 | regulation of complement activation (GO:0030449) | 4.04970769 |
| 75 | ethanol oxidation (GO:0006069) | 4.04595661 |
| 76 | tyrosine metabolic process (GO:0006570) | 4.03831691 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 4.03127870 |
| 78 | coenzyme catabolic process (GO:0009109) | 3.99512700 |
| 79 | protein localization to chromosome, centromeric region (GO:0071459) | 3.99203602 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.98251789 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.98251789 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.98251789 |
| 83 | homocysteine metabolic process (GO:0050667) | 3.97305644 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 3.88246678 |
| 85 | negative regulation of sterol transport (GO:0032372) | 3.88246678 |
| 86 | cellular ketone body metabolic process (GO:0046950) | 3.86985353 |
| 87 | acylglycerol homeostasis (GO:0055090) | 3.86295675 |
| 88 | triglyceride homeostasis (GO:0070328) | 3.86295675 |
| 89 | phospholipid efflux (GO:0033700) | 3.83719897 |
| 90 | DNA replication initiation (GO:0006270) | 3.83691149 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81398679 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81398679 |
| 93 | erythrocyte maturation (GO:0043249) | 3.78635232 |
| 94 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.78394893 |
| 95 | cellular amino acid catabolic process (GO:0009063) | 3.78224677 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 3.75984333 |
| 97 | amine catabolic process (GO:0009310) | 3.74671479 |
| 98 | cellular biogenic amine catabolic process (GO:0042402) | 3.74671479 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.73120698 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.70236502 |
| 101 | L-serine metabolic process (GO:0006563) | 3.69797042 |
| 102 | DNA strand elongation (GO:0022616) | 3.67966572 |
| 103 | mitotic nuclear envelope disassembly (GO:0007077) | 3.67749896 |
| 104 | imidazole-containing compound metabolic process (GO:0052803) | 3.66322815 |
| 105 | drug transmembrane transport (GO:0006855) | 3.65511991 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.65256082 |
| 107 | indolalkylamine metabolic process (GO:0006586) | 3.64510023 |
| 108 | iron coordination entity transport (GO:1901678) | 3.62600430 |
| 109 | response to nitrosative stress (GO:0051409) | 3.61250028 |
| 110 | establishment of integrated proviral latency (GO:0075713) | 3.61161428 |
| 111 | very long-chain fatty acid metabolic process (GO:0000038) | 3.57322178 |
| 112 | * tetrapyrrole metabolic process (GO:0033013) | 3.57192831 |
| 113 | protein-lipid complex subunit organization (GO:0071825) | 3.55263957 |
| 114 | response to mercury ion (GO:0046689) | 3.54776928 |
| 115 | mitotic metaphase plate congression (GO:0007080) | 3.54285789 |
| 116 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.53173530 |
| 117 | bile acid and bile salt transport (GO:0015721) | 3.52920048 |
| 118 | chromosome condensation (GO:0030261) | 3.51916347 |
| 119 | membrane disassembly (GO:0030397) | 3.51320483 |
| 120 | nuclear envelope disassembly (GO:0051081) | 3.51320483 |
| 121 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.51214014 |
| 122 | cellular modified amino acid catabolic process (GO:0042219) | 3.50551170 |
| 123 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.49546772 |
| 124 | cholesterol homeostasis (GO:0042632) | 3.48460930 |
| 125 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.48324499 |
| 126 | cellular protein complex localization (GO:0034629) | 3.47869814 |
| 127 | COPI coating of Golgi vesicle (GO:0048205) | 3.46910970 |
| 128 | Golgi transport vesicle coating (GO:0048200) | 3.46910970 |
| 129 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.44474661 |
| 130 | cellular glucuronidation (GO:0052695) | 3.43962861 |
| 131 | fibrinolysis (GO:0042730) | 3.43685401 |
| 132 | sterol homeostasis (GO:0055092) | 3.42549581 |
| 133 | arginine metabolic process (GO:0006525) | 3.41487590 |
| 134 | ribosome assembly (GO:0042255) | 3.39112682 |
| 135 | oxygen transport (GO:0015671) | 3.33906901 |
| 136 | regulation of mitotic spindle organization (GO:0060236) | 3.33518749 |
| 137 | protein localization to kinetochore (GO:0034501) | 3.31137700 |
| 138 | DNA duplex unwinding (GO:0032508) | 3.22895768 |
| 139 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.21031035 |
| 140 | positive regulation of chromosome segregation (GO:0051984) | 3.18594627 |
| 141 | protein export from nucleus (GO:0006611) | 3.16562400 |
| 142 | gas transport (GO:0015669) | 3.15599217 |
| 143 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.15245361 |
| 144 | regulation of translational termination (GO:0006449) | 3.13707492 |
| 145 | protein complex localization (GO:0031503) | 3.11431168 |
| 146 | DNA conformation change (GO:0071103) | 3.10570449 |
| 147 | DNA geometric change (GO:0032392) | 3.08394129 |
| 148 | erythrocyte development (GO:0048821) | 3.02763446 |
| 149 | DNA synthesis involved in DNA repair (GO:0000731) | 3.02375757 |
| 150 | iron ion import (GO:0097286) | 3.02206730 |
| 151 | regulation of chromosome segregation (GO:0051983) | 3.01778010 |
| 152 | mRNA stabilization (GO:0048255) | 2.99051503 |
| 153 | RNA stabilization (GO:0043489) | 2.99051503 |
| 154 | telomere maintenance via recombination (GO:0000722) | 2.97533309 |
| 155 | chromatin assembly (GO:0031497) | 2.96996967 |
| 156 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.96937466 |
| 157 | DNA packaging (GO:0006323) | 2.95970591 |
| 158 | ribosomal large subunit biogenesis (GO:0042273) | 2.95712581 |
| 159 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.95065067 |
| 160 | regulation of spindle organization (GO:0090224) | 2.90919958 |
| 161 | mitotic recombination (GO:0006312) | 2.88973696 |
| 162 | establishment of viral latency (GO:0019043) | 2.88715639 |
| 163 | ribosomal small subunit biogenesis (GO:0042274) | 2.88348997 |
| 164 | maturation of SSU-rRNA (GO:0030490) | 2.86007754 |
| 165 | nuclear envelope organization (GO:0006998) | 2.84556883 |
| 166 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.80100333 |
| 167 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.80100333 |
| 168 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.80100333 |
| 169 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.79903062 |
| 170 | DNA replication checkpoint (GO:0000076) | 2.79366937 |
| 171 | heterochromatin organization (GO:0070828) | 2.79311058 |
| 172 | chromosome segregation (GO:0007059) | 2.77189857 |
| 173 | regulation of translational elongation (GO:0006448) | 2.75237354 |
| 174 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.71182623 |
| 175 | establishment of chromosome localization (GO:0051303) | 2.70617032 |
| 176 | metaphase plate congression (GO:0051310) | 2.69545947 |
| 177 | tRNA aminoacylation for protein translation (GO:0006418) | 2.67504771 |
| 178 | negative regulation of DNA repair (GO:0045738) | 2.65843112 |
| 179 | ribosome biogenesis (GO:0042254) | 2.64912291 |
| 180 | mitochondrial fusion (GO:0008053) | 2.63020630 |
| 181 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.62934497 |
| 182 | regulation of histone H3-K9 methylation (GO:0051570) | 2.62238867 |
| 183 | protein localization to chromosome (GO:0034502) | 2.59343099 |
| 184 | meiotic chromosome segregation (GO:0045132) | 2.58631516 |
| 185 | proline metabolic process (GO:0006560) | 2.58207457 |
| 186 | regulation of protein export from nucleus (GO:0046825) | 2.56992525 |
| 187 | tetrahydrofolate metabolic process (GO:0046653) | 2.54843482 |
| 188 | tRNA aminoacylation (GO:0043039) | 2.54114353 |
| 189 | amino acid activation (GO:0043038) | 2.54114353 |
| 190 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.53817878 |
| 191 | innate immune response in mucosa (GO:0002227) | 2.53309119 |
| 192 | embryonic process involved in female pregnancy (GO:0060136) | 2.52878201 |
| 193 | G1 DNA damage checkpoint (GO:0044783) | 2.52103530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.17698281 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.60324411 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.23528210 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.56060006 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.59562486 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 4.48301246 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.40014387 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.84123458 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.63457508 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60459766 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.53181122 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.37799323 |
| 13 | * GATA1_19941826_ChIP-Seq_K562_Human | 3.25615442 |
| 14 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.24521490 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.22791210 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.06274634 |
| 17 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.66489002 |
| 18 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.62068977 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.55404721 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.47296749 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.44173988 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.38223284 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.37843140 |
| 24 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.36698133 |
| 25 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.31868791 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.26051240 |
| 27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.16091665 |
| 28 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.15778598 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.15513906 |
| 30 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.04674244 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6747614 |
| 32 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.99321300 |
| 33 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.97270876 |
| 34 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.89834131 |
| 35 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89545899 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.89401657 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87975485 |
| 38 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.86049707 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81021139 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80869282 |
| 41 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.78791822 |
| 42 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.70970320 |
| 43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.69855388 |
| 44 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.65467717 |
| 45 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.62274293 |
| 46 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.62088449 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.61536007 |
| 48 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.60654704 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.58466126 |
| 50 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57065124 |
| 51 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56432620 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.56323204 |
| 53 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.49115132 |
| 54 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.44032365 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43596828 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42561070 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.38831327 |
| 58 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.36967294 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36873283 |
| 60 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.35550521 |
| 61 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.35276556 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34831109 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34187646 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33676554 |
| 65 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.33463037 |
| 66 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.30842790 |
| 67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.30747659 |
| 68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.30695143 |
| 69 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.30214621 |
| 70 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26846375 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.25364413 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25151111 |
| 73 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25123014 |
| 74 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22431323 |
| 75 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22154550 |
| 76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21226609 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20534734 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20506483 |
| 79 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.14629254 |
| 80 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.14604387 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12496660 |
| 82 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11470404 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11224055 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11220194 |
| 85 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.10855660 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10235473 |
| 87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10103089 |
| 88 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09461916 |
| 89 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09047589 |
| 90 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.08835874 |
| 91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08436236 |
| 92 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.07725476 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06340070 |
| 94 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03204351 |
| 95 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02516320 |
| 96 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02179994 |
| 97 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01689286 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00701390 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00613885 |
| 100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99944814 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99337807 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98791462 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98468215 |
| 104 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97476450 |
| 105 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96963819 |
| 106 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96418717 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95270212 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92981460 |
| 109 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91948199 |
| 110 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91759177 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91489628 |
| 112 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.90654856 |
| 113 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89301651 |
| 114 | MAF_26560356_Chip-Seq_TH1_Human | 0.89031034 |
| 115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87369198 |
| 116 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.85332812 |
| 117 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84789858 |
| 118 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.83940018 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83914042 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83870115 |
| 121 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.83830420 |
| 122 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.80763891 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80415808 |
| 124 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79710052 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78732775 |
| 126 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76673650 |
| 127 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72792903 |
| 128 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.71771739 |
| 129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.70730401 |
| 130 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67522300 |
| 131 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67239446 |
| 132 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.64313969 |
| 133 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64070007 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.63581810 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62345450 |
| 136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.62171825 |
| 137 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.61119612 |
| 138 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60753839 |
| 139 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.59758269 |
| 140 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.59648468 |
| 141 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.59185275 |
| 142 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.59083493 |
| 143 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58071722 |
| 144 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.57348976 |
| 145 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56981254 |
| 146 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.56081430 |
| 147 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.55330605 |
| 148 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.54298233 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54222268 |
| 150 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54108701 |
| 151 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53427333 |
| 152 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.52449157 |
| 153 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.52361946 |
| 154 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.52080173 |
| 155 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.51327479 |
| 156 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.50188857 |
| 157 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.49326717 |
| 158 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48410081 |
| 159 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.48225761 |
| 160 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.47528737 |
| 161 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.47180388 |
| 162 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46954676 |
| 163 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.45693171 |
| 164 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.45112653 |
| 165 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.43550227 |
| 166 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.43340080 |
| 167 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.43171638 |
| 168 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43138217 |
| 169 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.42302960 |
| 170 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.42276412 |
| 171 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.41787777 |
| 172 | NCOR_22424771_ChIP-Seq_293T_Human | 0.41655473 |
| 173 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41556760 |
| 174 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41342140 |
| 175 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.40285821 |
| 176 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.39780236 |
| 177 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.39438201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.45522312 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 6.38226194 |
| 3 | MP0005360_urolithiasis | 6.35992566 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.59484658 |
| 5 | MP0004147_increased_porphyrin_level | 5.12502260 |
| 6 | MP0005365_abnormal_bile_salt | 4.87787888 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.78799546 |
| 8 | MP0005083_abnormal_biliary_tract | 4.39545387 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 4.24766779 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 3.75124870 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 3.49723653 |
| 12 | MP0010094_abnormal_chromosome_stability | 3.49399678 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 3.36024436 |
| 14 | MP0008057_abnormal_DNA_replication | 3.33766590 |
| 15 | MP0003693_abnormal_embryo_hatching | 3.25007853 |
| 16 | MP0003252_abnormal_bile_duct | 3.23505997 |
| 17 | MP0009840_abnormal_foam_cell | 2.96987412 |
| 18 | MP0003077_abnormal_cell_cycle | 2.85519614 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.83876556 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.80678906 |
| 21 | MP0003195_calcinosis | 2.70853488 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.43551931 |
| 23 | MP0005332_abnormal_amino_acid | 2.36222142 |
| 24 | MP0001730_embryonic_growth_arrest | 2.12622604 |
| 25 | MP0005076_abnormal_cell_differentiation | 2.05762264 |
| 26 | MP0000350_abnormal_cell_proliferation | 1.97904930 |
| 27 | MP0000609_abnormal_liver_physiology | 1.96859460 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.93138986 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.92756868 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.81969887 |
| 31 | MP0003868_abnormal_feces_composition | 1.77560456 |
| 32 | MP0008058_abnormal_DNA_repair | 1.72888614 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.71389242 |
| 34 | MP0002009_preneoplasia | 1.71384631 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.71117166 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.68952955 |
| 37 | MP0008932_abnormal_embryonic_tissue | 1.62118282 |
| 38 | MP0010307_abnormal_tumor_latency | 1.61624978 |
| 39 | MP0005380_embryogenesis_phenotype | 1.56629303 |
| 40 | MP0001672_abnormal_embryogenesis/_devel | 1.56629303 |
| 41 | MP0001697_abnormal_embryo_size | 1.55580315 |
| 42 | MP0005451_abnormal_body_composition | 1.53639384 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51413305 |
| 44 | MP0002080_prenatal_lethality | 1.49824971 |
| 45 | MP0003984_embryonic_growth_retardation | 1.49444247 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.48859377 |
| 47 | MP0002086_abnormal_extraembryonic_tissu | 1.47730014 |
| 48 | MP0003186_abnormal_redox_activity | 1.47677113 |
| 49 | MP0000920_abnormal_myelination | 1.46262050 |
| 50 | MP0000313_abnormal_cell_death | 1.45590660 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 1.43672133 |
| 52 | MP0008007_abnormal_cellular_replicative | 1.41923835 |
| 53 | MP0002088_abnormal_embryonic_growth/wei | 1.40638398 |
| 54 | MP0002006_tumorigenesis | 1.38199952 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.34451708 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.31283198 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.28300273 |
| 58 | MP0001764_abnormal_homeostasis | 1.27503679 |
| 59 | MP0001348_abnormal_lacrimal_gland | 1.25288139 |
| 60 | MP0003690_abnormal_glial_cell | 1.24370095 |
| 61 | MP0009643_abnormal_urine_homeostasis | 1.24058526 |
| 62 | MP0001727_abnormal_embryo_implantation | 1.19390310 |
| 63 | MP0003329_amyloid_beta_deposits | 1.18063422 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 1.13112029 |
| 65 | MP0000598_abnormal_liver_morphology | 1.10024286 |
| 66 | MP0005257_abnormal_intraocular_pressure | 1.09419651 |
| 67 | MP0000604_amyloidosis | 1.09313749 |
| 68 | MP0008961_abnormal_basal_metabolism | 1.09142542 |
| 69 | MP0000490_abnormal_crypts_of | 1.08879742 |
| 70 | MP0004264_abnormal_extraembryonic_tissu | 1.08681476 |
| 71 | MP0002084_abnormal_developmental_patter | 1.08223312 |
| 72 | MP0002019_abnormal_tumor_incidence | 1.07488066 |
| 73 | MP0005621_abnormal_cell_physiology | 1.06724158 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.05538262 |
| 75 | MP0002060_abnormal_skin_morphology | 1.04236499 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 1.02635064 |
| 77 | MP0002398_abnormal_bone_marrow | 1.00063530 |
| 78 | MP0002085_abnormal_embryonic_tissue | 0.97984859 |
| 79 | MP0003011_delayed_dark_adaptation | 0.96309454 |
| 80 | MP0004197_abnormal_fetal_growth/weight/ | 0.95164544 |
| 81 | MP0009763_increased_sensitivity_to | 0.94791531 |
| 82 | MP0003786_premature_aging | 0.94641520 |
| 83 | MP0001881_abnormal_mammary_gland | 0.94492579 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.91963897 |
| 85 | MP0005384_cellular_phenotype | 0.91929058 |
| 86 | MP0004233_abnormal_muscle_weight | 0.91400526 |
| 87 | MP0005647_abnormal_sex_gland | 0.90986316 |
| 88 | MP0009697_abnormal_copulation | 0.90408952 |
| 89 | MP0009764_decreased_sensitivity_to | 0.90056333 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.89770809 |
| 91 | MP0008872_abnormal_physiological_respon | 0.88208421 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.86327761 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.85490394 |
| 94 | MP0000358_abnormal_cell_content/ | 0.84816376 |
| 95 | MP0004043_abnormal_pH_regulation | 0.84179575 |
| 96 | MP0002722_abnormal_immune_system | 0.82370577 |
| 97 | MP0000858_altered_metastatic_potential | 0.81414639 |
| 98 | MP0001915_intracranial_hemorrhage | 0.81260220 |
| 99 | MP0001529_abnormal_vocalization | 0.80623506 |
| 100 | MP0005408_hypopigmentation | 0.79459868 |
| 101 | MP0003943_abnormal_hepatobiliary_system | 0.78859296 |
| 102 | MP0003890_abnormal_embryonic-extraembry | 0.74800058 |
| 103 | MP0000685_abnormal_immune_system | 0.73895206 |
| 104 | MP0002429_abnormal_blood_cell | 0.72379653 |
| 105 | MP0004272_abnormal_basement_membrane | 0.72340376 |
| 106 | MP0001873_stomach_inflammation | 0.72099965 |
| 107 | MP0004947_skin_inflammation | 0.71212265 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.70037808 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.69506699 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.68864928 |
| 111 | MP0001661_extended_life_span | 0.68742842 |
| 112 | MP0000689_abnormal_spleen_morphology | 0.68545236 |
| 113 | MP0008438_abnormal_cutaneous_collagen | 0.66007738 |
| 114 | MP0005266_abnormal_metabolism | 0.65964622 |
| 115 | MP0008260_abnormal_autophagy | 0.65295588 |
| 116 | MP0009379_abnormal_foot_pigmentation | 0.65087707 |
| 117 | MP0009278_abnormal_bone_marrow | 0.64391129 |
| 118 | MP0008469_abnormal_protein_level | 0.64078666 |
| 119 | MP0002092_abnormal_eye_morphology | 0.63886096 |
| 120 | MP0005501_abnormal_skin_physiology | 0.63676148 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.62510490 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 0.61451417 |
| 123 | MP0003950_abnormal_plasma_membrane | 0.61071926 |
| 124 | MP0003091_abnormal_cell_migration | 0.61022039 |
| 125 | MP0003941_abnormal_skin_development | 0.60672566 |
| 126 | MP0005334_abnormal_fat_pad | 0.60457495 |
| 127 | MP0003315_abnormal_perineum_morphology | 0.59241492 |
| 128 | MP0006035_abnormal_mitochondrial_morpho | 0.57910402 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.57480545 |
| 130 | MP0004381_abnormal_hair_follicle | 0.56913246 |
| 131 | MP0002971_abnormal_brown_adipose | 0.56104626 |
| 132 | MP0002132_abnormal_respiratory_system | 0.55230486 |
| 133 | MP0005535_abnormal_body_temperature | 0.54789436 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.54666256 |
| 135 | MP0008873_increased_physiological_sensi | 0.51870722 |
| 136 | MP0009931_abnormal_skin_appearance | 0.50776000 |
| 137 | MP0002229_neurodegeneration | 0.49596020 |
| 138 | MP0003632_abnormal_nervous_system | 0.49236419 |
| 139 | MP0003718_maternal_effect | 0.48575904 |
| 140 | MP0000747_muscle_weakness | 0.47833736 |
| 141 | MP0005220_abnormal_exocrine_pancreas | 0.47239765 |
| 142 | MP0008775_abnormal_heart_ventricle | 0.46495879 |
| 143 | MP0004142_abnormal_muscle_tone | 0.46407477 |
| 144 | MP0009672_abnormal_birth_weight | 0.46219726 |
| 145 | MP0001756_abnormal_urination | 0.44402062 |
| 146 | MP0003300_gastrointestinal_ulcer | 0.44181811 |
| 147 | MP0004885_abnormal_endolymph | 0.42401349 |
| 148 | MP0000639_abnormal_adrenal_gland | 0.41933047 |
| 149 | MP0005666_abnormal_adipose_tissue | 0.41483994 |
| 150 | MP0008874_decreased_physiological_sensi | 0.39587516 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.38930850 |
| 152 | MP0003631_nervous_system_phenotype | 0.37310070 |
| 153 | MP0003453_abnormal_keratinocyte_physiol | 0.37126985 |
| 154 | MP0004130_abnormal_muscle_cell | 0.36287225 |
| 155 | MP0000579_abnormal_nail_morphology | 0.35208208 |
| 156 | MP0005448_abnormal_energy_balance | 0.35016510 |
| 157 | MP0001765_abnormal_ion_homeostasis | 0.34588602 |
| 158 | MP0005084_abnormal_gallbladder_morpholo | 0.34257441 |
| 159 | MP0002796_impaired_skin_barrier | 0.33967798 |
| 160 | MP0001545_abnormal_hematopoietic_system | 0.33534879 |
| 161 | MP0005397_hematopoietic_system_phenotyp | 0.33534879 |
| 162 | MP0001243_abnormal_dermal_layer | 0.33291301 |
| 163 | MP0009053_abnormal_anal_canal | 0.33228259 |
| 164 | MP0008770_decreased_survivor_rate | 0.28970137 |
| 165 | MP0003075_altered_response_to | 0.28786333 |
| 166 | MP0002970_abnormal_white_adipose | 0.28784376 |
| 167 | MP0003633_abnormal_nervous_system | 0.28705693 |
| 168 | MP0005670_abnormal_white_adipose | 0.28349853 |
| 169 | MP0010678_abnormal_skin_adnexa | 0.27369251 |
| 170 | MP0005452_abnormal_adipose_tissue | 0.27189303 |
| 171 | MP0003111_abnormal_nucleus_morphology | 0.25765340 |
| 172 | MP0010771_integument_phenotype | 0.25487968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Poikilocytosis (HP:0004447) | 7.85999920 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 7.29663427 |
| 3 | Acanthocytosis (HP:0001927) | 6.89752508 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 6.40728425 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.00085056 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 5.85676437 |
| 7 | Deep venous thrombosis (HP:0002625) | 5.79175046 |
| 8 | Reticulocytosis (HP:0001923) | 5.33654451 |
| 9 | Xanthomatosis (HP:0000991) | 5.21401554 |
| 10 | Hyperbilirubinemia (HP:0002904) | 5.20330447 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.10360155 |
| 12 | Cholelithiasis (HP:0001081) | 5.06565770 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.94095895 |
| 14 | Abnormal gallbladder morphology (HP:0012437) | 4.93283161 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.88926975 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.56189539 |
| 17 | Abnormal gallbladder physiology (HP:0012438) | 4.17019861 |
| 18 | Cholecystitis (HP:0001082) | 4.17019861 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 3.71726804 |
| 20 | Complement deficiency (HP:0004431) | 3.70261016 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.66908873 |
| 22 | Hyperammonemia (HP:0001987) | 3.62677962 |
| 23 | Abnormality of the gallbladder (HP:0005264) | 3.61971143 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.59464230 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.54050069 |
| 26 | Progressive external ophthalmoplegia (HP:0000590) | 3.51972177 |
| 27 | Joint hemorrhage (HP:0005261) | 3.49564307 |
| 28 | Epidermoid cyst (HP:0200040) | 3.46195995 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.45562063 |
| 30 | Ankyloglossia (HP:0010296) | 3.40984207 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.40053320 |
| 32 | Paralysis (HP:0003470) | 3.35435365 |
| 33 | Ketosis (HP:0001946) | 3.34770262 |
| 34 | Hyperglycinemia (HP:0002154) | 3.33604610 |
| 35 | Fat malabsorption (HP:0002630) | 3.32074688 |
| 36 | Hepatocellular carcinoma (HP:0001402) | 3.26664410 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.22782027 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 3.22782027 |
| 39 | Abnormality of reticulocytes (HP:0004312) | 3.14838944 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 3.06463304 |
| 41 | Chromsome breakage (HP:0040012) | 3.02191409 |
| 42 | Hypoglycemic coma (HP:0001325) | 2.99154865 |
| 43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.98226268 |
| 44 | Ileus (HP:0002595) | 2.97280230 |
| 45 | * Insomnia (HP:0100785) | 2.96195697 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87898882 |
| 47 | Metabolic acidosis (HP:0001942) | 2.78881540 |
| 48 | Abnormality of oral frenula (HP:0000190) | 2.75621403 |
| 49 | Orthostatic hypotension (HP:0001278) | 2.75238027 |
| 50 | Abnormal hemoglobin (HP:0011902) | 2.72672068 |
| 51 | Abnormality of iron homeostasis (HP:0011031) | 2.72594817 |
| 52 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.72558071 |
| 53 | Hypercholesterolemia (HP:0003124) | 2.70138815 |
| 54 | Osteomalacia (HP:0002749) | 2.68780624 |
| 55 | Dysmetric saccades (HP:0000641) | 2.67618625 |
| 56 | Hyperglycinuria (HP:0003108) | 2.67199748 |
| 57 | Increased nuchal translucency (HP:0010880) | 2.66267329 |
| 58 | Rickets (HP:0002748) | 2.65377253 |
| 59 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.65368662 |
| 60 | Increased serum ferritin (HP:0003281) | 2.63704963 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.63318065 |
| 62 | Microcytic anemia (HP:0001935) | 2.58370796 |
| 63 | Abnormality of complement system (HP:0005339) | 2.57938667 |
| 64 | Polycythemia (HP:0001901) | 2.56370473 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.56152449 |
| 66 | Steatorrhea (HP:0002570) | 2.53856820 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.52874583 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.52217322 |
| 69 | Delayed CNS myelination (HP:0002188) | 2.52056354 |
| 70 | Termporal pattern (HP:0011008) | 2.48838216 |
| 71 | Insidious onset (HP:0003587) | 2.48838216 |
| 72 | Leiomyosarcoma (HP:0100243) | 2.45054496 |
| 73 | Uterine leiomyosarcoma (HP:0002891) | 2.45054496 |
| 74 | Hypochromic anemia (HP:0001931) | 2.43214459 |
| 75 | Abnormality of serum amino acid levels (HP:0003112) | 2.42938940 |
| 76 | Pallor (HP:0000980) | 2.40718628 |
| 77 | Microvesicular hepatic steatosis (HP:0001414) | 2.39996060 |
| 78 | Progressive muscle weakness (HP:0003323) | 2.36241362 |
| 79 | Hyperacusis (HP:0010780) | 2.30847042 |
| 80 | Spastic paraparesis (HP:0002313) | 2.30196795 |
| 81 | Missing ribs (HP:0000921) | 2.29377379 |
| 82 | Abnormality of nucleobase metabolism (HP:0010932) | 2.28439232 |
| 83 | Brushfield spots (HP:0001088) | 2.23896679 |
| 84 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.21676215 |
| 85 | Gastrointestinal carcinoma (HP:0002672) | 2.21676215 |
| 86 | Ketoacidosis (HP:0001993) | 2.21613949 |
| 87 | Hypertensive crisis (HP:0100735) | 2.21128766 |
| 88 | Abnormality of the gastric mucosa (HP:0004295) | 2.20265356 |
| 89 | Poikiloderma (HP:0001029) | 2.19024311 |
| 90 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.18697813 |
| 91 | Birth length less than 3rd percentile (HP:0003561) | 2.18610423 |
| 92 | Squamous cell carcinoma (HP:0002860) | 2.17537879 |
| 93 | Pili torti (HP:0003777) | 2.17151797 |
| 94 | Hypophosphatemic rickets (HP:0004912) | 2.15509691 |
| 95 | Neurofibrillary tangles (HP:0002185) | 2.15252264 |
| 96 | Spontaneous abortion (HP:0005268) | 2.14780742 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14296216 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.14296216 |
| 99 | Abnormality of the fingertips (HP:0001211) | 2.11917827 |
| 100 | Lethargy (HP:0001254) | 2.11137590 |
| 101 | Multiple enchondromatosis (HP:0005701) | 2.09667506 |
| 102 | Cerebral edema (HP:0002181) | 2.09239861 |
| 103 | 11 pairs of ribs (HP:0000878) | 2.07335084 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 2.06379813 |
| 105 | Microglossia (HP:0000171) | 2.05716769 |
| 106 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.05606040 |
| 107 | Cerebral inclusion bodies (HP:0100314) | 2.05528501 |
| 108 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.04604352 |
| 109 | Onycholysis (HP:0001806) | 2.04598449 |
| 110 | Entropion (HP:0000621) | 2.03350345 |
| 111 | Bladder neoplasm (HP:0009725) | 2.03156816 |
| 112 | Bladder carcinoma (HP:0002862) | 2.03156816 |
| 113 | Fatigue (HP:0012378) | 2.02447781 |
| 114 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.01823582 |
| 115 | Global brain atrophy (HP:0002283) | 2.01702753 |
| 116 | Overlapping toe (HP:0001845) | 2.01451416 |
| 117 | Vascular calcification (HP:0004934) | 2.01224047 |
| 118 | Cafe-au-lait spot (HP:0000957) | 2.00859186 |
| 119 | Upper limb muscle weakness (HP:0003484) | 2.00095195 |
| 120 | Hemorrhage of the eye (HP:0011885) | 1.98620275 |
| 121 | Irritability (HP:0000737) | 1.97010287 |
| 122 | Deviation of the thumb (HP:0009603) | 1.94323189 |
| 123 | Gingival bleeding (HP:0000225) | 1.94085131 |
| 124 | Cortical dysplasia (HP:0002539) | 1.93708067 |
| 125 | Myelodysplasia (HP:0002863) | 1.92438480 |
| 126 | Gastrointestinal stroma tumor (HP:0100723) | 1.90648525 |
| 127 | Proximal placement of thumb (HP:0009623) | 1.89619417 |
| 128 | * Vomiting (HP:0002013) | 1.88078397 |
| 129 | Hypoglycemic seizures (HP:0002173) | 1.87865933 |
| 130 | Renal cell carcinoma (HP:0005584) | 1.86862313 |
| 131 | Myocardial infarction (HP:0001658) | 1.86331553 |
| 132 | Uterine neoplasm (HP:0010784) | 1.86234264 |
| 133 | Reticulocytopenia (HP:0001896) | 1.85783983 |
| 134 | Acute myeloid leukemia (HP:0004808) | 1.85596174 |
| 135 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.85119639 |
| 136 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.85119639 |
| 137 | Nonimmune hydrops fetalis (HP:0001790) | 1.83873374 |
| 138 | Ridged nail (HP:0001807) | 1.83535198 |
| 139 | Amyloidosis (HP:0011034) | 1.83419051 |
| 140 | Skin nodule (HP:0200036) | 1.82449144 |
| 141 | Subacute progressive viral hepatitis (HP:0006572) | 1.81617768 |
| 142 | Nausea (HP:0002018) | 1.81311411 |
| 143 | Vertebral arch anomaly (HP:0008438) | 1.80685142 |
| 144 | Gout (HP:0001997) | 1.80670761 |
| 145 | Abnormality of glycolysis (HP:0004366) | 1.79489748 |
| 146 | Increased serum pyruvate (HP:0003542) | 1.79489748 |
| 147 | Opisthotonus (HP:0002179) | 1.76461976 |
| 148 | Neoplasm of the colon (HP:0100273) | 1.76301432 |
| 149 | IgA deficiency (HP:0002720) | 1.76174719 |
| 150 | Spastic diplegia (HP:0001264) | 1.75353842 |
| 151 | Menorrhagia (HP:0000132) | 1.75272861 |
| 152 | Lower limb hyperreflexia (HP:0002395) | 1.75151128 |
| 153 | Sensorimotor neuropathy (HP:0007141) | 1.75071401 |
| 154 | Axonal loss (HP:0003447) | 1.74902299 |
| 155 | Abnormality of the preputium (HP:0100587) | 1.74438198 |
| 156 | Overriding aorta (HP:0002623) | 1.72889718 |
| 157 | Increased connective tissue (HP:0009025) | 1.72153053 |
| 158 | Cardiovascular calcification (HP:0011915) | 1.71707433 |
| 159 | Elfin facies (HP:0004428) | 1.71570466 |
| 160 | Impaired proprioception (HP:0010831) | 1.71106947 |
| 161 | Osteolytic defects of the hand bones (HP:0009699) | 1.70786364 |
| 162 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70786364 |
| 163 | Malnutrition (HP:0004395) | 1.70781323 |
| 164 | Abnormality of urine glucose concentration (HP:0011016) | 1.69662997 |
| 165 | Glycosuria (HP:0003076) | 1.69662997 |
| 166 | Osteomyelitis (HP:0002754) | 1.69553874 |
| 167 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68590797 |
| 168 | Viral hepatitis (HP:0006562) | 1.66005781 |
| 169 | Progressive hearing impairment (HP:0001730) | 1.64096303 |
| 170 | Short middle phalanx of the 5th finger (HP:0004220) | 1.63258631 |
| 171 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.63026862 |
| 172 | Relative macrocephaly (HP:0004482) | 1.61836253 |
| 173 | Basal cell carcinoma (HP:0002671) | 1.60660580 |
| 174 | Aplasia cutis congenita (HP:0001057) | 1.60332518 |
| 175 | Long palpebral fissure (HP:0000637) | 1.59060458 |
| 176 | Increased mean platelet volume (HP:0011877) | 1.57976111 |
| 177 | Selective tooth agenesis (HP:0001592) | 1.55702496 |
| 178 | Toxemia of pregnancy (HP:0100603) | 1.54716956 |
| 179 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.54468439 |
| 180 | Premature skin wrinkling (HP:0100678) | 1.54190872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 4.67423121 |
| 2 | BCKDK | 4.13170421 |
| 3 | STK39 | 3.68706247 |
| 4 | TLK1 | 3.47729424 |
| 5 | MST4 | 3.21151433 |
| 6 | PRPF4B | 3.18377292 |
| 7 | SCYL2 | 3.00528801 |
| 8 | EPHB1 | 2.92770508 |
| 9 | BUB1 | 2.92311131 |
| 10 | SMG1 | 2.66497449 |
| 11 | STK4 | 2.65770733 |
| 12 | TAOK3 | 2.54437066 |
| 13 | PBK | 2.52582817 |
| 14 | OXSR1 | 2.40510563 |
| 15 | PKN1 | 2.37368167 |
| 16 | SIK1 | 2.33359021 |
| 17 | MET | 2.24837143 |
| 18 | MAPKAPK5 | 2.11767238 |
| 19 | MAPK11 | 1.94753778 |
| 20 | WEE1 | 1.86007927 |
| 21 | WNK4 | 1.84784689 |
| 22 | FGFR4 | 1.77229869 |
| 23 | TAF1 | 1.66675896 |
| 24 | NEK2 | 1.65426524 |
| 25 | TSSK6 | 1.63322312 |
| 26 | ERBB4 | 1.62982138 |
| 27 | NEK1 | 1.59879718 |
| 28 | EIF2AK3 | 1.50628063 |
| 29 | CDK12 | 1.50503500 |
| 30 | ERN1 | 1.49394065 |
| 31 | RPS6KA5 | 1.40019535 |
| 32 | KSR2 | 1.37752376 |
| 33 | TRIB3 | 1.36455445 |
| 34 | CDC7 | 1.34831460 |
| 35 | STK10 | 1.31167382 |
| 36 | ABL2 | 1.29914891 |
| 37 | MAP3K10 | 1.26757007 |
| 38 | ICK | 1.26062732 |
| 39 | BMPR2 | 1.25586375 |
| 40 | LATS2 | 1.24751115 |
| 41 | NEK9 | 1.23631577 |
| 42 | MAP3K8 | 1.23418639 |
| 43 | SRPK1 | 1.22005707 |
| 44 | MAP3K14 | 1.21795111 |
| 45 | CHEK2 | 1.21585682 |
| 46 | SGK494 | 1.21384834 |
| 47 | SGK223 | 1.21384834 |
| 48 | JAK2 | 1.21140053 |
| 49 | INSRR | 1.19180273 |
| 50 | BRAF | 1.18911340 |
| 51 | TAOK2 | 1.17349241 |
| 52 | CCNB1 | 1.15416140 |
| 53 | ERBB2 | 1.14709805 |
| 54 | RPS6KB2 | 1.13551489 |
| 55 | STK24 | 1.11263086 |
| 56 | GRK6 | 1.07465452 |
| 57 | PKN2 | 1.05682359 |
| 58 | TRPM7 | 1.05022577 |
| 59 | MAP2K3 | 1.04387669 |
| 60 | MAP3K11 | 1.01556614 |
| 61 | FLT3 | 0.99157461 |
| 62 | CDK6 | 0.98970253 |
| 63 | PRKAA2 | 0.98624870 |
| 64 | PLK4 | 0.94829144 |
| 65 | PRKCQ | 0.92676657 |
| 66 | BMX | 0.91647911 |
| 67 | DYRK3 | 0.88207437 |
| 68 | KSR1 | 0.88060213 |
| 69 | PRKAA1 | 0.87602532 |
| 70 | PLK1 | 0.85634302 |
| 71 | CDK7 | 0.85250375 |
| 72 | ZAK | 0.84516023 |
| 73 | CDK4 | 0.84105698 |
| 74 | PASK | 0.83991676 |
| 75 | CSNK1D | 0.83961782 |
| 76 | MELK | 0.82520331 |
| 77 | WNK1 | 0.81127774 |
| 78 | IRAK3 | 0.79528563 |
| 79 | FGFR2 | 0.79307436 |
| 80 | NME2 | 0.77150254 |
| 81 | EPHA2 | 0.76839422 |
| 82 | AURKA | 0.76468389 |
| 83 | BRSK1 | 0.76188523 |
| 84 | BRSK2 | 0.76018768 |
| 85 | ALK | 0.75864432 |
| 86 | MAP3K13 | 0.75654567 |
| 87 | PLK3 | 0.75218497 |
| 88 | RAF1 | 0.74865070 |
| 89 | TESK2 | 0.74484628 |
| 90 | PDPK1 | 0.73737518 |
| 91 | STK3 | 0.73154601 |
| 92 | MST1R | 0.71742252 |
| 93 | LATS1 | 0.71737285 |
| 94 | AKT2 | 0.71317527 |
| 95 | MAP2K2 | 0.70950468 |
| 96 | NTRK1 | 0.70440442 |
| 97 | RIPK4 | 0.70338314 |
| 98 | PRKACG | 0.69842059 |
| 99 | EIF2AK2 | 0.69750904 |
| 100 | PIM1 | 0.69416516 |
| 101 | MAPK12 | 0.69208496 |
| 102 | PDGFRA | 0.67682103 |
| 103 | DYRK1B | 0.67485230 |
| 104 | GSK3A | 0.66427348 |
| 105 | FGFR1 | 0.66321698 |
| 106 | TTK | 0.65162315 |
| 107 | RPS6KA4 | 0.64895962 |
| 108 | MAP2K4 | 0.64405534 |
| 109 | DAPK2 | 0.64073074 |
| 110 | ATR | 0.63518248 |
| 111 | CSNK1G3 | 0.63028277 |
| 112 | MAP3K7 | 0.61227181 |
| 113 | CAMK2G | 0.60928632 |
| 114 | UHMK1 | 0.59976921 |
| 115 | MAP3K9 | 0.59143895 |
| 116 | TNIK | 0.58960050 |
| 117 | LRRK2 | 0.56984937 |
| 118 | CSNK1G1 | 0.55692943 |
| 119 | MAP3K2 | 0.55447145 |
| 120 | CDK19 | 0.52985445 |
| 121 | PAK4 | 0.52557293 |
| 122 | PINK1 | 0.51260668 |
| 123 | CAMK2B | 0.50416985 |
| 124 | CSNK1A1L | 0.47878437 |
| 125 | EEF2K | 0.47635173 |
| 126 | VRK1 | 0.46701847 |
| 127 | CDK2 | 0.45622795 |
| 128 | ATM | 0.45350841 |
| 129 | PNCK | 0.45335436 |
| 130 | CDK8 | 0.44366992 |
| 131 | ERBB3 | 0.44353484 |
| 132 | PRKD1 | 0.43894372 |
| 133 | PDK1 | 0.43654473 |
| 134 | FGR | 0.43640232 |
| 135 | PRKACB | 0.43297427 |
| 136 | CDK1 | 0.41923924 |
| 137 | ARAF | 0.41718908 |
| 138 | PIK3CG | 0.41490028 |
| 139 | BRD4 | 0.40768360 |
| 140 | MTOR | 0.40417285 |
| 141 | CSNK2A2 | 0.37965312 |
| 142 | SGK1 | 0.37130354 |
| 143 | PRKCZ | 0.36724888 |
| 144 | MAP2K1 | 0.36704306 |
| 145 | CAMK1D | 0.36431133 |
| 146 | DAPK3 | 0.36275277 |
| 147 | SGK3 | 0.36101764 |
| 148 | CLK1 | 0.35066022 |
| 149 | RPS6KA3 | 0.34927177 |
| 150 | AURKB | 0.34203354 |
| 151 | MKNK1 | 0.33796973 |
| 152 | TYK2 | 0.33768967 |
| 153 | KDR | 0.33390876 |
| 154 | RET | 0.32641569 |
| 155 | CSNK1E | 0.32336155 |
| 156 | YES1 | 0.32230667 |
| 157 | CSNK1G2 | 0.31322726 |
| 158 | CHEK1 | 0.31138162 |
| 159 | MAP3K1 | 0.30969035 |
| 160 | CDK9 | 0.30873253 |
| 161 | ROCK2 | 0.29780620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.90046617 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.76425560 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53031766 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 3.03625247 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92591218 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.88369421 |
| 7 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.85955308 |
| 8 | Cell cycle_Homo sapiens_hsa04110 | 2.81950266 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81078479 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55524930 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.53885204 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52918553 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.46982325 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42844568 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31023748 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.28837722 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26152581 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24862432 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23491119 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.19763258 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.17730493 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.14480596 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.13530366 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.10199129 |
| 25 | RNA transport_Homo sapiens_hsa03013 | 2.00401387 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94763194 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.90872954 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.89612375 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88798732 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88744551 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.79457296 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77607789 |
| 33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.77506067 |
| 34 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.73691387 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72199166 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68123720 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67715137 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64863425 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62363835 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.61951759 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.60657668 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60249932 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.57078453 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56830105 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.56650973 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53291883 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48355360 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48317544 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.48164625 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.47068593 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 1.45501977 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45435274 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45156687 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.43597863 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43524057 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39805103 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 1.39656659 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38597748 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36412103 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31578946 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28549395 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27048321 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23543926 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22374807 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20275316 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19041365 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17486574 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16797054 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16119709 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13183852 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 1.05327101 |
| 72 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.04588413 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 1.04441558 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04353586 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03247463 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03036102 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02515159 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99678860 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98739972 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96637383 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95998656 |
| 82 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95897295 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.95355182 |
| 84 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95113343 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92973709 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91314040 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91059472 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90688938 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.90625088 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.89432359 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87776054 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.85243465 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85222463 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.84429012 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.83950466 |
| 96 | Measles_Homo sapiens_hsa05162 | 0.83561949 |
| 97 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82998884 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82341316 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82121681 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81766801 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79790441 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78928532 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72605571 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.69027744 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.67129639 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66944912 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66857454 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65524378 |
| 109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63804045 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62201505 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61823718 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61661068 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.61533554 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61031294 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61014742 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.59755088 |
| 117 | Proteasome_Homo sapiens_hsa03050 | 0.58573331 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57193009 |
| 119 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57087078 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56620386 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56328794 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53657154 |
| 123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53554001 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51024427 |
| 125 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49576291 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49463927 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49286936 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48728348 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46558978 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45416142 |
| 131 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44938338 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44792021 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44042213 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42055518 |
| 135 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.41919763 |
| 136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39563960 |
| 137 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.38590676 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38293953 |
| 139 | Purine metabolism_Homo sapiens_hsa00230 | 0.38049601 |
| 140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34926186 |
| 141 | Alcoholism_Homo sapiens_hsa05034 | 0.34764439 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32223802 |
| 143 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32017592 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30642041 |
| 145 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16339383 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.15917754 |
| 147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15286953 |
| 148 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13939336 |
| 149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06704819 |
| 150 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.04907952 |
| 151 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02601554 |
| 152 | Bladder cancer_Homo sapiens_hsa05219 | 0.01228541 |
| 153 | Insulin resistance_Homo sapiens_hsa04931 | 0.01072191 |
| 154 | Galactose metabolism_Homo sapiens_hsa00052 | -0.2119278 |
| 155 | Hepatitis C_Homo sapiens_hsa05160 | -0.2053973 |
| 156 | Mineral absorption_Homo sapiens_hsa04978 | -0.1974652 |
| 157 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1911307 |
| 158 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.1866194 |
| 159 | Protein export_Homo sapiens_hsa03060 | -0.1676003 |
| 160 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.1544048 |
| 161 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1300358 |
| 162 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1145580 |
| 163 | Viral carcinogenesis_Homo sapiens_hsa05203 | -0.1101687 |
| 164 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1050866 |
| 165 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0955619 |
| 166 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0806386 |
| 167 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | -0.0795409 |
| 168 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0610347 |
| 169 | Malaria_Homo sapiens_hsa05144 | -0.0262405 |
| 170 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0195150 |

